Molecular suitability of the Chacma baboon model of acquired thrombotic thrombocytopenic purpura when evaluating anti-VWF agents

ISTH Academy, Walter Janse Van Rensburg, 263784

Impact of Von Willebrand Factor deficiency on placental development and angiogenesis

ISTH Academy, Mario von Depka, 263785

Correlation of tissue factor- and phospholipid-activated thrombin generation assays with tail bleeding in hemophilia A mice treated with coagulation factor VIIa

ISTH Academy, Mikhail V. Ovanesov, 263801

Generation of Transgenic Zebrafish with RFP-Labeled Young and GFP-Labeled Mature Thrombocytes: Analysis of Their Lipids

ISTH Academy, Pudur Jagadeeswaran, 263803

The effect of Antithrombin Budapest3 mutation for the heparin binding affinity of Antithrombin

ISTH Academy, Krisztina Pénzes-Daku, 263804

Effect of Brazilian snake venoms on hemostasis evaluated by thrombin generation assay

ISTH Academy, Luci Dusse, 263818

The shortened activation peptide of Pseudonaja textilis venom FX confers zymogenicity and resistance to factor VIIIa-IXa activation

ISTH Academy, Mark Schreuder, 263819

Variability in Venom Coagulotoxins in Russell’s Vipers (genus: Daboia) Compromise Antivenom Effectiveness

ISTH Academy, Bianca op den Brouw, 263820

Plasma kallikrein contributes to coagulation by activating factor IX

ISTH Academy, Mayken Visser, 263836

Potential Contribution of Kallikrein to the Coagulation System Independent of Factor XII Activation

ISTH Academy, Juliet Butler, 263837

Misfolded proteins can differentially modulate the contact system

ISTH Academy, Lewis Hardy, 263839

Phenotype and genotype of FXIII deficiency in two unrelated probands: identification of a novel F13A1 large deletion mediated by complex rearrangement

ISTH Academy, Qiulan Ding, 263853

Genetic Characterization of two new Families with Congenital Factor XIII Deficiency. A new Missense Mutation of gene F13

ISTH Academy, ANGEL ZUÑIGA, 263854

Clinical and Molecular Characterization by NGS of Spanish Patients affected by Congenital Deficiency of Fibrinogen

ISTH Academy, Santiago Bonanad, 263855

Evolving Amiloride into uPA-targeting Candidates for the Treatment of Metastatic Cancer and Rheumatoid Arthritis

ISTH Academy, Benjamin Buckley, 263871

Heparanase: a potential new factor concerned to epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma

ISTH Academy, Massoud Mirshahi, 263872

Fibrin deposit on the peritoneal surface serve as a niche for cancer expansion in carcinomatosis patients

ISTH Academy, Massoud Mirshahi, 263873

A Survey of Physicians’ Treatment Switching Practice in Long-term Prophylaxis for People with Haemophilia A in five European Countries

ISTH Academy, Sally Tawil, 263887

Long-term outcomes after switch from on-demand treatment to prophylaxis with rFIXFc: longitudinal subgroup analysis of the B-LONG and B-YOND study population

ISTH Academy, Hervé Chambost, 263888

Timing of Treated Spontaneous Bleeding in Persons with Haemophilia A (PwHA) in the HAVEN 3 Study

ISTH Academy, Johnny Mahlangu, 263889

Expert Opinion on the UK Standard of Care for Haemophilia Patients with Inhibitors: A Delphi Consensus Study

ISTH Academy, Kate Khair, 263903

Population Pharmacokinetics of rVIII-SingleChain in Obese Previously Treated Patients with Severe Hemophilia A in Study CSL627_1001

ISTH Academy, William McKeand, 263904

Emicizumab Improves Factor X Activation and Thrombin Generation Similar to Mild Hemophilia in Persons with Hemophilia A and Inhibitors

ISTH Academy, Marilyn Manco-Johnson, 263905

HOSPITALIZATION OF HEMOPHILIA A and B PATIENTS IN BRAZIL - TRENDS FROM 2004 TO 2016

ISTH Academy, ANA GUERSONI, 263920

The Impact on Australian Haemophilia Nursing Roles after the Introduction of an Interim Agreement of Extended Half Life Products for the Treatment of Haemophilia

ISTH Academy, Robyn Shoemark, 263921

ADVANCE-AF: An international, prospective, longitudinal, observational registry study of hemophilia patients with atrial fibrillation

ISTH Academy, Roger Schutgens, 263922

Effect of lower von Willebrand factor and factor XI levels on treatment success of the levonorgestrel intrauterine system or endometrial ablation in heavy menstrual bleeding - an explorative study

ISTH Academy, Karina Meijer, 263937

Educational guidance and training program for patients in the eminence of home therapy for factor XIII deficiency

ISTH Academy, Ricardo Camelo, 263938

Combined factor V and factor VIII deficiency: A Clinico-haematological Spectrum

ISTH Academy, Mostafa Paridar, 263939

Detection and Analysis of Gene Mutations in Patients with Factor VII deficiency by Next Generation Sequencing

ISTH Academy, Boyang Sun, 263953

Coexisting mild hemophilia B and von Willebrand´s disease type 1: a rare multiple congenital coagulopathy

ISTH Academy, Michael Steiner, 263954

A nightmare in congenital factor XIII deficiency:Inhibitor development with severe bleeding

ISTH Academy, Serap Karaman, 263955

Safety and Efficacy of Fibrinogen Concentrate in Congenital Fibrinogen Deficiency: A Post-marketing Observational Study

ISTH Academy, Bruce Schwartz, 263969

Hypoprothrombinemia-Lupus Anticoagulant Syndrome (HLAS) Case report

ISTH Academy, Daniela Brito, 263970

Rare Bleeding Disorder Manifestations in Women and Girls: Experience Of One Center In Algiers

ISTH Academy, Nawel Ferroudj, 263971

Genotype-phenotype and pathophysiological mechanisms involved in patients with von Willebrand disease (VWD) type 2A and 2M according to domains affected by genetic clinical-grade variants (CGV)

ISTH Academy, Adriana Inés Woods, 263986

Gastrointestinal Angiodysplasia and Von Willebrand Disease: Our Experience of Managing Challenging Bleeding

ISTH Academy, Gary Benson, 263987

A Novel Mechanism in Severe Type 1 VWD: a Heterozygous Splicing Mutation Causes Exon 26 Skipping and Increases VWF Clearance

ISTH Academy, Mattia Ferrarese, 263988

Management of Postpartum Haemorrhage in a Woman with Type 2B Von Willebrand Disease

ISTH Academy, Samuel Ackroyd, 264002

Safety and Efficacy of pdVWF/FVIII in Patients with von Willebrand Disease Undergoing Prophylaxis: Results from a Non-interventional Multicentre Study

ISTH Academy, Joseph Lasky, 264003

Determination of Large and Ultra-large Multimers in Recombinant Human VWF (rVWF) and Pharmacokinetic Analyses in Patients with Type 3 von Willebrand Disease (VWD)

ISTH Academy, Peter. L Turecek, 264005

It takes a village… The implementation of a multidisciplinary clinic review for children and adolescents with bleeding disorders

ISTH Academy, Jaime Chase, 264021

Current Nursing Workloads and Implications for the Future within Haemophilia Treatment Centres in Australia

ISTH Academy, Susan Webzell, 264022

National benchmarking of Paediatric Haemophilia Treatment Centres

ISTH Academy, Stacey Hutchison, 264023

Therapeutic aspects, determining the outcome of deep veins thrombosis (DVT) in children with hematological diseases

ISTH Academy, Daria Fedorova, 264039

Genetic and Clinical Determinants Influencing Warfarin Dosing in Thai Children And Adolescents

ISTH Academy, Premmika Intapun, 264040

Septic Dural Sinus Thrombosis In Children

ISTH Academy, Patcharee Komvilaisak, 264041

Platelet Phenotype and Function in Paediatric Extracorporeal Membrane Oxygenation (ECMO) Circuits

ISTH Academy, Hui Ping Yaw, 264055

Endothelial and Platelet Activations in α-thalassemia Diseases

ISTH Academy, Pankamol Sirivadhanakul, 264056

Characteristics of young patients with retinal occlusion

ISTH Academy, Dorit Blickstein, 264057

THE INCIDENCEOF VENOUS THROMBOEMBOLISM IN THROMBOPHILIC CHILDREN: A PROSPECTIVE COHORT STUDY

ISTH Academy, Daniela Tormene, 264071

Multidisciplinary Approach to Pediatric Thrombosis; Istanbul Pediatric Thrombosis (I-PeT) Study Group Experience

ISTH Academy, Zeynep Karakas, 264072

Symptomatic and incidental VTE in children differs in epidemiology and outcomes

ISTH Academy, Daria Fedorova, 264073

Incidence and Risk Factors for Peripherally Inserted Central Catheter-Related Venous Thrombosis in Critically-Ill Children with Cardiac Disease: a Retrospective Single-Center Case-Control Study

ISTH Academy, Jennifer Meldau, 264089

Use of low molecular weight heparins in pediatric thromboembolism: a retrospective descriptive study

ISTH Academy, Claudia DJAMBAS KHAYAT, 264090

A 10-year case-control study on the risk factors for neonatal portal vein thrombosis

ISTH Academy, Tuan Nguyen Minh, 264091

The Interactions of Protamine and Heparin with Platelets in Rodents

ISTH Academy, Joanna Miklosz, 264105

Optimal “timing” of low-dose aspirin by aggregation and thromboelastometry tests in patients with essential thrombocythemia

ISTH Academy, Emma Cacciola, 264106

Astragalus polysaccharide promotes haematopoiesis and thrombopoiesis in irradiation mouse models

ISTH Academy, Mo Yang, 264107

The first homozygous GNE variant in the P-loop of the ManNAc kinase domain causes severe macrothrombocytopenia and bleeding

ISTH Academy, Marie-Christine Morel-Kopp, 264122

Outcome of an enhanced diagnostic pipeline for patients suspected for inherited thrombocytopenia

ISTH Academy, Eva Leinoe, 264123

Prospective comparison of Whole Mount Electron Microscopy and mepacrine based flow cytometric assay for determination of Platelet Dense Granules and Platelet Dense Granule Deficiency

ISTH Academy, Timothy Brighton, 264124

Platelet function testing: current practice among clinical centers in the Nordic countries

ISTH Academy, Riita Lassila, 264138

The utility of flow cytometric platelet forward scatter as an alternative to mean platelet volume

ISTH Academy, David Connor, 264139

Correlation between mutations and clinical features in patients with essential thrombocythemia

ISTH Academy, Mankai Ju, 264140

TLT-1 expression during megakaryocyte differentiation

ISTH Academy, Angela Doerr, 264155

The effect of a new packing container on medication adherence Department of Pharmacy

ISTH Academy, Kana Aoki, 264156

An empirical screen of the effects of polyphenolic compounds on platelet scramblase activity

ISTH Academy, Sarah Millington-Burgess, 264157

Platelet-specific factor XIII-A: A novel role in the regulation of platelet function

ISTH Academy, Joanne Mitchell, 264173

Fatal Dysfunction and Disintegration of Thrombin-Activated Platelets

ISTH Academy, John Weisel, 264175

Blood clot contraction is promoted by calpain via strengthening of the coupling of fibrin-bound αIIbβ3 to the platelet cytoskeleton

ISTH Academy, John Weisel, 264176

Effect of recombinant human lactoferrin, isolated from transgenic goats, on platelet aggregation and Ca2+-response

ISTH Academy, Ekaterina Shamova, 264190

Extracellular vesicle shedding from stimulated platelets involves phosphatidylserine exposure in addition to a functional αIIbβ3integrin

ISTH Academy, Tilman M. Hackeng, 264191

Platelet Integrin αIIbβ3-dependent Outside-in Signaling Is Regulated by Apoptosis Signal-regulating Kinase 1 Through p38 MAP Kinase Signaling

ISTH Academy, Meghna Naik, 264193

Laboratory measurement of rivaroxaban using anti-factor Xa assays in patients with cancer-associated thrombosis

ISTH Academy, Eunha Koh, 264207

Coagulation Factors and Natural Anticoagulants in Polycythemia Vera Patients, Relation with JAK2V617F Mutation Load

ISTH Academy, Natalia Silina, 264208

Improving care for patients with Cancer Associated Thrombosis in the Netherlands using patients´, caregivers´ and health care professionals´ experiences

ISTH Academy, Asiong Jie, 264209

Apixaban as treatment for Cancer Related Venous Thrombosis - A single arm interventional study

ISTH Academy, Trine-Lise Hannevik, 264224

Superficial Vein Thrombosis and Cancer

ISTH Academy, Jana Hirmerova, 264225

Coagulation profile in non Hematoloic malignancies

ISTH Academy, Sushma Belurkar, 264226

Incidence Of Venous Thromboembolism (VTE) In Childhood Cancers - Tertiary Care Centre Experience From Kingdom Of Saudi Arabia

ISTH Academy, Mahasen Saleh, 264241

Role of microRNAs in venous thromboembolic disease of patients with lung cancer

ISTH Academy, Julia Oto, 264242

DOACs and cancer-associated thrombosis: effect of online CME on knowledge and confidence of physicians

ISTH Academy, Jelena Spyropoulos, 264243

A Retrospective Analysis of the real-world use of Idarucizumab at Two Tertiary Care Centres in Toronto, Canada

ISTH Academy, Jameel Abdulrehman, 264257

Reversal of warfarin using low dose Prothromplex Total, a 4-factor prothrombin complex and its implications on fix-dosing regimens

ISTH Academy, Shu Hui Yeang, 264258

Perioperative management of anticoagulant therapies in elderly patients undergoing orthopedic surgery: preliminary results from the ORTHO-START registry

ISTH Academy, Elvira Grandone, 264259

Idarucizumab for dabigatran reversal, the first 6 months in a tertiary center

ISTH Academy, Matt Wheeler, 264260

Effect of polypharmacy on bleeding of rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism

ISTH Academy, Ingrid Bistervels, 264275

Risk factors for gastro-intestinal bleeding associated with DOACs: a case control- study

ISTH Academy, Cecilia Becattini, 264276

Factor Xa inhibitor antidote, Andexanet alfa differentially reverses the effects of Apixaban, Betrixaban, Edoxaban and Rivaroxaban

ISTH Academy, Fakiha Siddiqui, 264277

Management of oral anticoagulant reversal prior to emergency surgery: are we following guidelines in the United States?

ISTH Academy, Jerrold Levy, 264278

Effectof Anticoagulant treatment on Pain in Distal Deep Vein Thrombosis: An Ancillary Analysis from the CACTUS Trial

ISTH Academy, Marc Righini, 264293

Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequela; a retrospective cohort study performed with routine healthcare data from the Netherlands

ISTH Academy, Geert-Jan Geersing, 264294

Automated IVC filter retrieval requests and haematology liaison improves documentation and retrieval of temporary inferior vena cava filters: a quality improvement initiative

ISTH Academy, Lara N. Roberts, 264295

Outcomes in the secondary prevention of cerebral venous thrombosis in cancer only population

ISTH Academy, Cristhiam Mauricio Rojas Hernandez, 264310

Incidence and characteristics of venous thromboembolism in East Asian primary central nervous system lymphoma

ISTH Academy, Sung-Soo Yoon, 264312

Extended anticoagulation for unprovoked venous thromboembolism: a survey on physicians’ considerations and guideline adherence

ISTH Academy, Maria Adriana de Winter, 264314

Non-invasive detection of early phase of deep vein thrombus with diffusion-weighted magnetic resonance imaging

ISTH Academy, Toshihiro Gi, 264331

Incidence and characteristics of double lumen induced central venous catheter-related thromboembolism in hemodialytic patients

ISTH Academy, Andree Kurniawan, 264332

Evaluation of strategies focused on empowerment and change of behavior with a potential utility in patients with thromboembolic disorders

ISTH Academy, Luci Dusse, 264333